SlimTide

SlimTide is a commercial brand name for a compounded weight loss medication, typically formulated as a combination of the glucagon-like peptide-1 (GLP-1) receptor agonist **semaglutide** and **cyanocobalamin** (Vitamin B12). It is primarily distributed through wellness clinics, medical spas, and telehealth platforms for the treatment of obesity and chronic weight management. The primary active ingredient, semaglutide, functions by mimicking the endogenous GLP-1 hormone, which stimulates insulin secretion, inhibits glucagon release, and delays gastric emptying, leading to increased satiety and reduced appetite. As a compounded product, SlimTide is not a standalone FDA-approved proprietary drug product but is prepared by pharmacies to provide branded access to GLP-1 therapies, often marketed as a more affordable or accessible alternative to commercial products like Ozempic or Wegovy.

Brand names

SlimTide